NCT01324388
A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
See it on ClinicalTrials.gov ↗51 people
35.3%
64.7%
18 womenmiddle line = equal numbers33 men
- Phase
- PHASE1
- Paid for by
- Eli Lilly and Company
- Finished
- 2011-08
- Health conditions
- Diabetes Mellitus, Type 2
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 51.8 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 45.1% · Asian 23.5% · Black / African American 21.6% · More than one race 9.8% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Not reported 0%
Women left out
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Male participants: agree to use a reliable method of birth control during the study and for 3 months following the last dose of the investigational product”
- No hormone therapy
Women taking menopause hormones or gender-affirming hormones could not join.
“…within 7 days prior to dosing or prescription medication (with the exception of vitamin/mineral supplements and/or hormone replacement therapy and/or thyroid replacement therapy) within 14 days prior to dosing of the investigational product”
- Only women past menopause
Women who could still get pregnant were turned away.
“Female participants: women not of child-bearing potential due to menopause or surgical sterilization (at least 6 weeks post surgical bilateral oophorectomy, hysterectomy or tubal ligation) confirmed by medical history”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Have a body mass index (BMI) of 18.5 to 40.0 kilograms/square meter (kg/m\^2), inclusive at the time of screening”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Show history or evidence of significant active neuropsychiatric disease”
- No cancer
Women with current or past cancer were turned away.
“Have personal or family history of medullary thyroid cancer (MTC) or a genetic condition that predisposes to MTC”
Study titles and rules are shown in their original English.